from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3233c/-

LFCtreatmentdescriptionclass of inhibitor

-0.794

Amikacinug/mL Amikacintranslation

-0.487

Cap5-10ug/mL Capreomycintranslation

-1.308

Rox10-50 ug/mL Roxithromycintranslation

1.338

SM2-5 ug/mL Streptomycintranslation

-0.842

Tet5-10 ug/mL Tetracyclinetranslation

1.505

Rif0.2-5ug/mL Rifampicintranscription

0.634

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.635

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.879

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.866

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.583

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.926

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.770

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.133

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.514

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.130

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.795

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.242

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.141

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.377

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.800

KCN5-20 ug/mL Potassium cyaniderespiration

-0.162

NaN30.2-2 mM Sodium aziderespiration

-1.030

Nigericin50 uM Nigericinrespiration

0.421

TRC10-150 ug/mL Triclosanrespiration

-0.675

TRZ10-25 ug/mL Thioridazinerespiration

-2.482

Valinomycin0.5-10 uM Valinomycinrespiration

-0.647

ZnSO42 mM ZnSO4respiration

-0.556

menadione6-10 ug/mL Menadionerespiration

0.022

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.249

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.356

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.280

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.964

NRP_1Non-replicating persistence stage 1dosRassociated

0.750

Amp0.2mg/mL AmpicillincellWall

0.301

Cephalexin20-100 ug/mL CephalexincellWall

0.544

Cerulenin0.32-5 ug/mL CerulenincellWall

0.251

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.659

EMB10-20 ug/mL EthambutolcellWall

0.484

Eta12-40 ug/mL EthionamidecellWall

0.618

INH0.2-0.4 ug/mL IsoniazidcellWall

0.493

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.816

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.338

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.160

BZA0.12 mg/mL BenzamidearomaticAmides

0.138

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.521

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.581

H2O24 mM hydrogen peroxideDNAdamaging

-0.026

Levo10 ug/mL LevofloxacinDNAdamaging

0.352

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.893

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.747

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.576

UVUV-irradiationDNAdamaging

-1.141

ARP41-4 ug/mL Antitubercular compound ARP4?

0.189

Antimycin12.5-50 ug/mL Antimycin A?

-0.000

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.217

PA_110-50 ug/mL Antitubercular compound PA-1?

0.150

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.266

PA8240.2-2 ug/mL PA-824?

-0.358

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.198

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.869

Verapamil50 uM Verapamil?

-0.173

mercaptoethanol2 mM 2-Mercaptoethanol?

0.057

methoxatin10-20 ug/mL Methoxatin?